Heart Health Co. Sues Rival Over Genetic Test Patent
Boston Heart informed Health Diagnostic Laboratory Inc. that its genetic testing infringed U.S. Patent No. 8,455,194, which covers diagnostic methods for identifying individuals who are at risk of severe muscle aches and pains, or myopathy, caused by statin drugs used to reduce cholesterol levels.
But Boston Heart claims HDL has...
To view the full article, register now.